You are here
Technology Holding, LLC
UEI: U52NGYKN42H6
# of Employees: 12
HUBZone Owned: No
Socially and Economically Disadvantaged: Yes
Woman Owned: No
Award Charts
Award Listing
-
Novel Syn Bio Method to Produce Performance Advantaged Polymers
Amount: $1,650,000.00According to the US EPA, manufacturing activity contributes 21% of net greenhouse gas emissions. The largest component of these emissions is the use of fossil based raw materials. The petrochemicals a ...
SBIRPhase II2022Department of Energy -
Biomimetic production of Xanthommatin Biopigment for Thermally Functional UAV Coatings
Amount: $172,988.00This program will develop a novel, low environment, safety, and occupational health (ESOH) risk coating system capable of mitigating the long wave infrared (LWIR) signature of unmanned aerial vehicles ...
STTRPhase I2022Department of Defense Army -
Novel Food Ingredient with very high levels of Essential Amino Acids (EAA)
Amount: $172,909.00The proposed program will span the design, production, purification, and testing of a novel protein based food ingredient with >80% Essential Amino Acid content. A generally recognized as safe (GRAS) ...
STTRPhase I2022Department of Defense Army -
Autonomous Biomanufacturing at Remote Locations
Amount: $225,000.00Technology Holding proposes to demonstrate a semi-autonomous biomanufacturing platform capable of production of high-value molecules, optimized for remote deployment with minimal operator interaction ...
SBIRPhase I2022Department of Defense Defense Advanced Research Projects Agency -
Medical Sterilizer for Far Forward Austere Environments
Amount: $249,992.00The current steam based sterilizers have weight and power related challenges that limits their use to Role 3 environments. Further, due to high temperature of use, these are unsuitable for non-metalli ...
SBIRPhase I2022Department of Defense Defense Health Agency -
Novel Biologic Countermeasure for Acute Radiation Syndrome
Amount: $2,999,993.80Acute Radiation Syndrome (ARS) is an acute illness caused by irradiation of a significant portion of the body by a high dose of ionizing radiation (IR) in a short period of time. Global proliferation ...
SBIRPhase II2022Department of Defense Defense Health Agency -
Optimized Platforms for Proper Glycosylation and Sialylation of Recombinant Human Butyrylcholinesterase (rBChE)
Amount: $541,247.20The threat of organophosphate (OP) chemical warfare agents (CWA) to United States military personnel is a persistent problem due to the relative ease of manufacturing chemical threats compared to nucl ...
SBIRPhase II2021Department of Defense Office for Chemical and Biological Defense -
Development of Human Monoclonal Antibody Therapeutic against Klebsiella pneumoniae Infection
Amount: $249,562.98Antibiotic resistant infections are a principal concern for the Department of Defense and society at large due to the current lack of available treatments. Monoclonal antibodies represent a promising ...
SBIRPhase I2021Department of Defense Defense Health Agency -
Novel Honeycomb Hollow Carbon Fiber Composite
Amount: $149,986.00The current commercial polyacrylonitrile (PAN) based carbon fibers such as IM7 and T300 are limited in modulus at 155 and 130 N/tex respectively. In addition, these fibers are high density (1.75 – 1 ...
STTRPhase I2021Department of Defense Air Force -
Novel Honeycomb Hollow Carbon Fiber Composite
Amount: $750,000.00Carbon fiber based composited have enabled advanced aircrafts such as Boeing 787 and Airbus A350 wherein the fuel efficiency has improved by more than 10% by reducing the weight. The commercial carbon ...
STTRPhase II2021Department of Defense Air Force
